Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 11Withdrawn 2Completed 2Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 12Neoplasms 8Breast Neoplasms 5Triple Negative Breast Neoplasms 4Neoplasm Metastasis 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Ovarian Neoplasms 3Osteosarcoma 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Advanced Solid Tumor 2Advanced Gastric Cancer 2Thyroid Neoplasms 1Solid Tumor, Adult 1Sarcoma 1Quality of Life 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Metastatic Castration Resistant Prostate Cancer 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Fluorouracil 255Leucovorin 224Oxaliplatin 218Irinotecan 206Bevacizumab 200Capecitabine 144Cetuximab 136Panitumumab 68Folfox protocol 63regorafenib 50Colonoscopy 44pembrolizumab 42IFL protocol 39Radiotherapy 32Nivolumab 31Drug Therapy 27trifluridine tipiracil drug combination 26Gemcitabine 24Blood Specimen Collection 23Chemotherapy, Adjuvant 20Surveys and Questionnaires 19Celecoxib 19Surgical Procedures, Operative 16durvalumab 15Neoadjuvant Therapy 15Cyclophosphamide 14Cisplatin 14aflibercept 13Standard of Care 13Pemetrexed 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Colorectal Neoplasms × apatinib × Clear all
NCT03190616 2020-01-14

Apatinib in Refractory Colorectal Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Completed
54 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01531777 2015-04-03

Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
40 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡